North America Whole Slide Imaging Market

The whole slide imaging market in North America is expected to grow from US$ 223.83 million in 2022 to US$ 615.72 million by 2028. It is estimated to grow at a CAGR of 18.4% from 2022 to 2028.

Raising Technological Advancements in Whole Slide Imaging

The concept of whole slide imaging emerged in the late 1990s. In initial phase, the system utilized microscope and computer combination to capture composite slide image. However, the system required considerable amount of time for image acquisition. In order to overcome this limitation, technology companies used automated algorithms and high-speed systems to boost the speed of image acquisition. This technological development extends the area of application for whole slide imaging. For instance, in May 2021, Due to rapid advancements in clinical applications for whole slide imaging and digital pathology, the College of American Pathologists (CAP) has collaborated with the American Society for Clinical Pathology (ASCP) and the Association for Pathology Informatics (API) to update the guideline “Validating Whole Slide Imaging for Diagnostic Purposes in Pathology. The new guidelines will ensure patients get their pathologic diagnosis quickly with the same quality test results and thereby possibly receive treatment sooner. Continual advancements in computational algorithms and image capturing technologies are making a constructive impact on the development of whole slide imaging technologies. Improvements in this technology are leading to a better throughput, error reduction, quick and efficient image capturing, image archiving, and image sharing. For instance, in March 2019, NanoString announced launch of GeoMx Digital Spatial Profiler, a next generation whole slide imaging technology for detailed spatial profiling of nucleic acid molecules. The system was introduced at the American Association of Cancer Research Conference 2019. Further, in March 2022, Inspirata Inc. announced U.S. Food and Drug Administration (FDA) clearance for its Dynamyx digital pathology software. Dynamyx holds the first FDA clearance for digital pathology software with multiple scanners, thus permitting customers to select the finest scanners for their laboratory. This clearance enables Dynamyx customers to use whole slide images (WSIs) for primary diagnosis instead of traditional glass slides, yielding powerful benefits to pathologists and laboratories. Furthermore, in October 2019, Olympus Corporation announced launch of its SLIDEVIEW VS200, an advanced slide scanner for high-resolution image acquisition. The equipment is capable of high-speed data acquisition and image processing of tissue samples as well as single cell. Such technological developments are estimated to drive the adoption of whole slide imaging systems, which would eventually boost the market growth during the forecast period.

Market Overview

The whole slide imaging market in North America is further segmented into the US, Canada, and Mexico. The US held the largest share of the North America whole slide imaging market in 2021. The demand for the market in the region is anticipated to witness growth at a significant rate during the forecast period owing to various factors such as government investment in healthcare infrastructure, increasing awareness regarding the digital pathology along with strategic activities by the manufactures.

North America Whole Slide Imaging Market Revenue and Forecast to 2028 (US$ Million)

North America Whole Slide Imaging Strategic Insights

Strategic insights for the North America Whole Slide Imaging provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

North America Whole Slide Imaging Report Scope

North America Whole Slide Imaging Regional Insights

The geographic scope of the North America Whole Slide Imaging refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

North America Whole Slide Imaging Market Segmentation 

The North America whole slide imaging market is segmented into type, application, end user, and country.

• Based on type, the market is segmented into hardware, software, and services. The hardware segment registered the largest market share in 2022.
• Based on application, the market is segmented into telepathology, cytopathology, immunohistochemistry, and hematopathology. The telepathology segment held a larger market share in 2022.
• Based on end user, the market is segmented into academic research institutes, hospitals, pharmaceutical and biopharmaceutical companies, and laboratories. The academic research institutes segment held the largest market share in 2022. 
• Based on country, the market is segmented into the US, Canada, and Mexico. The US dominated the market share in 2022.

3DHISTECH Ltd.; Hamamatsu Photonics K.K.; Indica Labs; Inspirata Inc.; Leica Biosystems Nussloch GmbH (Danaher); Mikroscan Technologies, Inc.; Nikon Corporation; Olympus Corporation; Visiopharm A/S; Akoya Biosciences, Inc.; and Koninklijke Philips N.V. are the leading companies operating in the whole slide imaging market in the region.